Naltrexone in the treatment of opiate dependence.
D000293:Adolescent; D000328:Adult; D005500:Follow-Up Studies; D005544:Forecasting; D006556:Heroin Dependence / Q000534:rehabilitation; D006801:Humans; D008297:Male; D008691:Methadone; D009270:Naloxone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009271:Naltrexone / Q000009:adverse effects / Q000627:therapeutic use*; D009294:Narcotics; D009519:New York City; D011613:Psychotherapy; D011957:Receptors, Opioid / Q000187:drug effects; D012008:Recurrence; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D019966:Substance-Related Disorders / Q000523:psychology / Q000534:rehabilitation*
D009294:Narcotics; D011957:Receptors, Opioid; D009270:Naloxone; D009271:Naltrexone; D008691:Methadone